Explore ›
Finding
Finding
decline
Women with HIV and periconceptional dolutegravir exposure had significantly higher risk of pregnancy loss compared to women without HIV, with adjusted risk ratios of 1.73 in MarketScan and 1.41 in Medicaid.
| Effect size | aRR 1.41 |
| CI | 95% CI 1.30-1.54 |
| Comparator | Women without HIV (pregnancy loss rate 2460 per 10000 in MarketScan, 1780 per 10000 in Medicaid) |
| Effect summary | decline; aRR 1.41; CI: 95% CI 1.30-1.54 |
Connected entities
Interventions
Conditions
Populations
Source
PMC10614030
Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008–20: a national cohort study